Sarborg Limited Closes $10 Million Seed Round to Expand Proprietary Agentic Approach
Funding supports next-generation AI agent development and proprietary Intellectual Property, focused initially on pharmaceutical drug-repurposing Initial clients reporting commercial success, revolutionizing indication selection of lead programs Early commercial success and key partnerships signal strong market traction and scalability potential into